Challenges in Prostate Cancer Screening by Prostate Cancer Antigen

by Medindia Content Team on  June 19, 2007 at 3:37 PM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

Challenges in Prostate Cancer Screening  by Prostate Cancer Antigen
Screening for prostate cancer using prostate specific antigen (PSA) testing continues to be problematic. Even though it is unproven whether population-wide screening with PSA can reduce death, illness or disability from prostate cancer, testing has become common in North America.

A recent nation-wide survey indicates almost half of Canadian men over 50 years old are tested during their lifetime. In this review, Drs. Ian Thompson and Donna Ankerst examine the evidence in support of the blood test and then discuss how physicians should advise patients about the merits and drawbacks of the test.

In a related commentary, Dr. Michael Jewett and colleagues examine the evidence from two large studies indicating that the drug finasteride is beneficial in reducing both the size of enlarged prostate glands and the risk of prostate cancer.



Source: Eurekalert
JAY/J

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Iodine Deficiency Disorder Prostate Cancer Cancer and Homeopathy Trans-Urethral Resection of the Prostate Prostate Cancer Facts Cancer Facts Cancer Prostate Cancer: Treatment Options Prostate Specific Antigen [PSA] Importance of Health Screening Tests 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...